DIFFERIN Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Differin, and when can generic versions of Differin launch?
Differin is a drug marketed by Galderma Labs Lp and is included in five NDAs. There are nine patents protecting this drug and one Paragraph IV challenge.
This drug has fifty-six patent family members in twenty-two countries.
The generic ingredient in DIFFERIN is adapalene. There are twelve drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the adapalene profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Differin
A generic version of DIFFERIN was approved as adapalene by P AND L on June 2nd, 2010.
Summary for DIFFERIN
International Patents: | 56 |
US Patents: | 9 |
Applicants: | 1 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 142 |
Clinical Trials: | 22 |
Patent Applications: | 5,059 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DIFFERIN |
Drug Sales Revenues: | Drug sales revenues for DIFFERIN |
What excipients (inactive ingredients) are in DIFFERIN? | DIFFERIN excipients list |
DailyMed Link: | DIFFERIN at DailyMed |



Recent Clinical Trials for DIFFERIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bausch Health Americas, Inc. | Early Phase 1 |
Wake Forest University Health Sciences | Early Phase 1 |
Aurobindo Pharma Ltd | Phase 3 |
Pharmacology for DIFFERIN
Drug Class | Retinoid |
Anatomical Therapeutic Chemical (ATC) Classes for DIFFERIN
US Patents and Regulatory Information for DIFFERIN
DIFFERIN is protected by nine US patents.
Patents protecting DIFFERIN
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TOPICAL TREATMENT OF ACNE VULGARIS
Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACNE
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACNE
Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACNE
Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACNE
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACNE
Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACNE
Expired US Patents for DIFFERIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galderma Labs Lp | DIFFERIN | adapalene | SOLUTION;TOPICAL | 020338-001 | May 31, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | CREAM;TOPICAL | 020748-001 | May 26, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | SOLUTION;TOPICAL | 020338-001 | May 31, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DIFFERIN
See the table below for patents covering DIFFERIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 60325379 | ⤷ Try a Trial | |
South Korea | 101007161 | ⤷ Try a Trial | |
France | 2837101 | UTILISATION DE L'ACIDE 6-[1-ADAMANTYL)-4-METHOXYPHENYL]-2- NAPHTHOIQUE POUR LE TRAITEMENT DE DESORDRES DERMATOLOGIQUES | ⤷ Try a Trial |
Russian Federation | 2421216 | КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПО МЕНЬШЕЙ МЕРЕ ОДНО ПРОИЗВОДНОЕ НАФТОЕВОЙ КИСЛОТЫ И ПО МЕНЬШЕЙ МЕРЕ ОДНО СОЕДИНЕНИЕ ТИПА ПОЛИУРЕТАНОВОГО ПОЛИМЕРА ИЛИ ЕГО ПРОИЗВОДНОЕ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ (COMPOSITIONS CONTAINING AT LEAST ONE NAPHTHOIC ACID DERIVATIVE AND AT LEAST ONE COMPOUND OF POLYURETHANE POLYMER OR ITS DERIVATIVE, METHODS OF PRODUCING AND APPLYING THEREOF) | ⤷ Try a Trial |
Denmark | 172070 | ⤷ Try a Trial | |
Australia | 638223 | ⤷ Try a Trial | |
Japan | H0830015 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DIFFERIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1458369 | SPC/GB10/005 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111 |
1458369 | 08C0024 | France | ⤷ Try a Trial | PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218 |
0199636 | 300209 | Netherlands | ⤷ Try a Trial | 300209, 20060411, EXPIRES: 20070702 |
1458369 | 132008901685368 | Italy | ⤷ Try a Trial | PRODUCT NAME: ADAPALENE E BENZOILE PEROSSIDO(EPIDUO); AUTHORISATION NUMBER(S) AND DATE(S): 40440, 20071218;DA 038261018/M A 038261057/M, 20080618 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |